Krista Fogarty - Jan 19, 2022 Form 3 Insider Report for Lipocine Inc. (LPCN)

Role
Principal Accounting Officer
Signature
/s/ Krista Fogarty
Stock symbol
LPCN
Transactions as of
Jan 19, 2022
Transactions value $
$0
Form type
3
Date filed
1/27/2022, 08:15 AM
Next filing
May 17, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LPCN Stock Option (Right to Buy) Jan 19, 2022 Common Stock 46K $1.12 Direct F1
holding LPCN Stock Option (Right to Buy) Jan 19, 2022 Common Stock 46K $1.37 Direct F2
holding LPCN Stock Option (Right to Buy) Jan 19, 2022 Common Stock 26K $0.46 Direct F3
holding LPCN Stock Option (Right to Buy) Jan 19, 2022 Common Stock 5K $1.46 Direct F4
holding LPCN Stock Option (Right to Buy) Jan 19, 2022 Common Stock 15K $1.13 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of December 7, 2022, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorate basis over the following two years.
F2 Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of December 15, 2021, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorate basis over the following two years.
F3 Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of January 28, 2021, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorate basis over the following two years.
F4 Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of December 4, 2019, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorate basis over the following two years.
F5 Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of October 22, 2019, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorate basis over the following two years.